Brian C. Callaghan

12.7k total citations · 5 hit papers
178 papers, 8.4k citations indexed

About

Brian C. Callaghan is a scholar working on Neurology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Brian C. Callaghan has authored 178 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Neurology, 66 papers in Physiology and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Brian C. Callaghan's work include Pain Mechanisms and Treatments (53 papers), Botulinum Toxin and Related Neurological Disorders (43 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Brian C. Callaghan is often cited by papers focused on Pain Mechanisms and Treatments (53 papers), Botulinum Toxin and Related Neurological Disorders (43 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Brian C. Callaghan collaborates with scholars based in United States, Denmark and United Kingdom. Brian C. Callaghan's co-authors include Eva L. Feldman, Andrea L. Smith, Rodica Pop‐Busui, Hsinlin T. Cheng, Catherine L. Stables, David Bennett, Vijay Viswanathan, Kevin A. Kerber, James Burke and Vera Bril and has published in prestigious journals such as New England Journal of Medicine, JAMA and Genes & Development.

In The Last Decade

Brian C. Callaghan

167 papers receiving 8.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic neuropathy

2019 978 citations Eva L. Feldman, Brian C. Callaghan et al. profile →
Diabetic neuropathy: clinical manifestations and current treatments

2012 808 citations Brian C. Callaghan, Eva L. Feldman et al. The Lancet Neurology profile →
Enhanced glucose control for preventing and treating diabetic neuropathy

2012 412 citations Brian C. Callaghan, Eva L. Feldman et al. profile →
Neurological consequences of obesity

2017 363 citations Brian C. Callaghan, Eva L. Feldman et al. The Lancet Neurology profile →
Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

2022 196 citations Melissa A. Elafros, Henning Andersen et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian C. Callaghan United States	43	3.6k	3.0k	1.5k	1.3k	995	178	8.4k
Helen Petrovitch United States	63	3.8k 1.0×	3.2k 1.1×	1.5k 1.0×	1.0k 0.8×	816 0.8×	127	13.2k
G. Webster Ross United States	57	3.2k 0.9×	3.8k 1.3×	653 0.4×	1.1k 0.9×	1.4k 1.4×	102	11.6k
Ming‐Xin Tang United States	43	4.1k 1.1×	1.1k 0.4×	1.5k 1.0×	1.7k 1.3×	691 0.7×	75	10.0k
Vera Bril Canada	55	6.0k 1.7×	8.4k 2.8×	3.0k 2.0×	1.1k 0.8×	2.1k 2.1×	386	15.7k
Takeo Kato Japan	46	1.3k 0.4×	2.4k 0.8×	1.4k 0.9×	2.1k 1.6×	1.5k 1.5×	277	8.6k
James W. Russell United States	38	2.9k 0.8×	1.8k 0.6×	907 0.6×	1.3k 1.0×	880 0.9×	67	5.8k
Sandra Kalmijn Netherlands	40	1.9k 0.5×	1.3k 0.4×	621 0.4×	819 0.6×	649 0.7×	65	7.0k
Alexis Elbaz France	58	2.3k 0.6×	3.2k 1.1×	455 0.3×	1.6k 1.2×	1.4k 1.4×	177	10.7k
Patrick G. Kehoe United Kingdom	51	3.9k 1.1×	899 0.3×	501 0.3×	2.5k 1.9×	1.1k 1.1×	187	8.4k
Roberto Ceravolo Italy	49	1.2k 0.3×	4.3k 1.4×	449 0.3×	1.1k 0.8×	1.8k 1.8×	275	8.2k

Countries citing papers authored by Brian C. Callaghan

Since Specialization

Citations

This map shows the geographic impact of Brian C. Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian C. Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian C. Callaghan more than expected).

Fields of papers citing papers by Brian C. Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian C. Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian C. Callaghan. The network helps show where Brian C. Callaghan may publish in the future.

Co-authorship network of co-authors of Brian C. Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian C. Callaghan. A scholar is included among the top collaborators of Brian C. Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian C. Callaghan. Brian C. Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Callaghan, Brian C., Evan L. Reynolds, A. Gordon Smith, et al.. (2025). The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type. Annals of Clinical and Translational Neurology. 12(7). 1408–1417. 2 indexed citations

Reynolds, Evan L., et al.. (2025). Racial and Ethnic Differences in Peripheral Neuropathy Risk Factors Among United States Adults. Neurology. 105(3). e213851–e213851.

Callaghan, Brian C., Evan L. Reynolds, Melissa A. Elafros, et al.. (2025). Diagnostic Testing for Patients With Peripheral Neuropathy. JAMA Neurology. 82(4). 420–420.

Lin, Chun Chieh, et al.. (2025). Cost Trends of New-To-Market Neurologic Medications. Neurology. 104(6). e213428–e213428. 2 indexed citations

Elafros, Melissa A., Ghassan Bachuwa, Mousumi Banerjee, et al.. (2024). Prevalence and Risk Factors of Distal Symmetric Polyneuropathy Among Predominantly Non-Hispanic Black, Low-Income Patients. Neurology. 102(11). e209390–e209390. 4 indexed citations

Stino, Amro, Evan L. Reynolds, Maya Watanabe, & Brian C. Callaghan. (2024). Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain‐Barre Syndrome in the United States—2001 to 2018. Muscle & Nerve. 70(6). 1192–1199. 1 indexed citations

Watanabe, Maya, et al.. (2024). Possible sex and racial disparities in myasthenia gravis care. Muscle & Nerve. 70(4). 791–799. 2 indexed citations

Havenon, Adam de, et al.. (2024). Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization. Neurology. 102(8). e209248–e209248. 3 indexed citations

Lin, Chun Chieh, Brian C. Callaghan, James Burke, et al.. (2023). Prescription Opioid Initiation for Neuropathy, Headache, and Low Back Pain: A US Population-based Medicare Study. Journal of Pain. 24(12). 2268–2282. 3 indexed citations

10.

Reynolds, Evan L., Kristen Votruba, M. Watanabe, et al.. (2023). The Effect of Surgical Weight Loss on Cognition in Individuals with Class II/III Obesity. The journal of nutrition health & aging. 27(12). 1153–1161. 2 indexed citations

11.

Elafros, Melissa A., Henning Andersen, David Bennett, et al.. (2022). Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. The Lancet Neurology. 21(10). 922–936. 196 indexed citations breakdown →

12.

Watanabe, Maya, et al.. (2022). Diagnostic characteristics of nerve conduction study parameters for vasculitic neuropathy. Muscle & Nerve. 67(1). 45–51. 8 indexed citations

13.

Elafros, Melissa A., Brian C. Callaghan, Lesli E. Skolarus, et al.. (2022). Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review. Reviews in Endocrine and Metabolic Disorders. 24(2). 221–239. 16 indexed citations

14.

Guo, Kai, Masha G. Savelieff, Amy E. Rumora, et al.. (2021). Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1091–1109. 28 indexed citations

15.

Reynolds, Evan L., Gülçin Akıncı, Mousumi Banerjee, et al.. (2021). The determinants of complication trajectories in American Indians with type 2 diabetes. JCI Insight. 6(10). 6 indexed citations

16.

Kerber, Kevin A., et al.. (2020). What's happening in Innovations in Care Delivery. Neurology. 95(15). 685–685.

17.

Havenon, Adam de, John P. Ney, Brian C. Callaghan, et al.. (2020). Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States. Journal of Stroke and Cerebrovascular Diseases. 30(2). 105535–105535. 25 indexed citations

18.

Callaghan, Brian C., Evan L. Reynolds, Mousumi Banerjee, et al.. (2018). Longitudinal pattern of pain medication utilization in peripheral neuropathy patients. Pain. 160(3). 592–599. 20 indexed citations

19.

Callaghan, Brian C., Kevin A. Kerber, Kenneth M. Langa, et al.. (2015). Longitudinal patient-oriented outcomes in neuropathy. Neurology. 85(1). 71–79. 36 indexed citations

20.

Callaghan, Brian C., et al.. (2013). A Comparison New Car Assessment Program NCAP Requirements and Procedures Around the World. SAE technical papers on CD-ROM/SAE technical paper series. 1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact